MOH — authorised 21 July 1976
- Marketing authorisation holder: BRACCO
- Status: likely_approved
MOH authorised Sincalide on 21 July 1976
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 21 July 1976.
BRACCO holds the Israeli marketing authorisation.